Today, 20 million patients a year are injected with a radioactive isotope known as technetium-99, which helps in imaging used to diagnose a wide range of conditions. However, such treatments are being delayed by the temporary shutdown of a Canadian reactor which serves as North America's only source of technetium-99. The reactor may not open until mid-January. Article